Literature DB >> 3883918

Seatone in rheumatoid arthritis: a six-month placebo-controlled study.

J G Larkin, H A Capell, R D Sturrock.   

Abstract

Thirty-five patients with rheumatoid arthritis were randomly allocated to either Seatone (green-lipped mussel extract) or placebo in order to assess the former's claimed effectiveness in rheumatoid disease. After six months there was no significant improvement in any laboratory or clinical measurement of disease activity in the Seatone group. The patients on active drug fared no better than those on placebo. These results suggest that Seatone is not effective in rheumatoid arthritis.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3883918      PMCID： PMC1001605          DOI： 10.1136/ard.44.3.199

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  8 in total

1.  An assessment of grip strength measurement in rheumatoid arthritis.

Authors:  P Lee; A Baxter; W C Dick; J Webb
Journal:  Scand J Rheumatol       Date:  1974       Impact factor: 3.641

2.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

4.  Green-lipped mussel extract in arthritis.

Authors:  R G Gibson; S L Gibson
Journal:  Lancet       Date:  1981-02-21       Impact factor: 79.321

5.  Perna canaliculus in the treatment of rheumatoid arthritis.

Authors:  D E Caughey; R R Grigor; E B Caughey; P Young; P J Gow; A W Stewart
Journal:  Eur J Rheumatol Inflamm       Date:  1983

6.  Seatone in arthritis.

Authors:  R G Gibson; S L Gibson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-28

7.  Seatone is ineffective in rheumatoid arthritis.

Authors:  E C Huskisson; J Scott; R Bryans
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25

8.  Perna canaliculus in the treatment of arthritis.

Authors:  R G Gibson; S L Gibson; V Conway; D Chappell
Journal:  Practitioner       Date:  1980-09
  8 in total
  6 in total

1.  Treating inflammation: some (needless) difficulties for gaining acceptance of effective natural products and traditional medicines.

Authors:  D E Butters; M W Whitehouse
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

Review 2.  Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.

Authors:  H A Capell; M Brzeski
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  Seatone in rheumatoid arthritis.

Authors:  R G Gibson; S L Gibson
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

Review 4.  Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus.

Authors:  Christopher S Cobb; Edzard Ernst
Journal:  Clin Rheumatol       Date:  2005-10-12       Impact factor: 2.980

Review 5.  Perna canaliculus and the Intestinal Microbiome.

Authors:  Emma Tali Saltzman; Michael Thomsen; Sean Hall; Luis Vitetta
Journal:  Mar Drugs       Date:  2017-06-30       Impact factor: 5.118

6.  Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel.

Authors:  M W Whitehouse; T A Macrides; N Kalafatis; W H Betts; D R Haynes; J Broadbent
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.